Prednisolone Pediatric Dosing Guidelines

General Principles

The American Academy of Pediatrics recommends weight-based dosing (mg/kg) for simplicity in clinical practice, but body surface area dosing (mg/m²) is preferred by major guidelines because it parallels prednisolone metabolism better and reduces the risk of underdosing in younger children 1
For significantly overweight children, always use ideal body weight rather than actual weight to avoid unnecessary steroid exposure and increased side effects 2, 3, 1
The maximum daily dose is typically 60 mg, though up to 80 mg may be considered for specific severe conditions 3
Prednisolone and prednisone are equivalent and used interchangeably at the same dosage 2, 3

For acute asthma, the American Thoracic Society recommends 1-2 mg/kg/day (maximum 60 mg/day) as a single daily dose for 3-10 days, with no tapering needed if duration is less than 10 days 2, 1
For nephrotic syndrome, the International Study of Kidney Diseases in Children recommends 60 mg/m²/day or 2 mg/kg/day (maximum 60 mg/day) as a single morning dose for 4-6 weeks, followed by 40 mg/m²/day or 1.5 mg/kg/day (maximum 40 mg) on alternate days for 2-5 months with gradual tapering 3, 1
For autoimmune hepatitis, the American Association for the Study of Liver Diseases recommends starting with 1-2 mg/kg/day (maximum 60 mg/day) for two weeks, either alone or with azathioprine, then taper over 6-8 weeks to a maintenance dose of 0.1-0.2 mg/kg/day or 5 mg/day 3
For tuberculous pericarditis in children, the American Heart Association recommends beginning with approximately 1 mg/kg/day and tapering proportionately to adult dosing: equivalent to 60 mg/day for 4 weeks, 30 mg/day for 4 weeks, 15 mg/day for 2 weeks, and 5 mg/day for the final week 4
For Multisystem Inflammatory Syndrome in Children (MIS-C), the American College of Rheumatology recommends methylprednisolone 1-2 mg/kg/day IV in combination with IVIG 2 gm/kg; for refractory disease requiring intensification, escalate to methylprednisolone 10-30 mg/kg/day IV 5

Administer prednisolone as a single morning dose before 9 AM to align with physiologic cortisol rhythm and minimize hypothalamic-pituitary-adrenal axis suppression 3, 1
Essential monitoring includes growth parameters, blood pressure, Cushingoid features, and consideration of calcium and vitamin D supplementation during therapy 2, 3, 1
Common side effects include weight gain, increased appetite, cosmetic changes, and growth deceleration 2, 1
Severe side effects are uncommon but more likely after prolonged therapy exceeding 18 months 1

For courses longer than 2 weeks, gradual tapering is essential to prevent adrenal insufficiency; reduce the dose by 25-33% at appropriate intervals once clinical response is achieved, with final reductions of 1 mg monthly 2, 1

Maintenance therapy can be effective with a minimum dose of approximately 0.3 mg/kg/day of prednisolone. This low‑dose regimen has been shown to maintain clinical benefit while limiting steroid exposure. 6
The preferred daily regimen for DMD is 0.75 mg/kg/day of prednisone administered every morning, rather than alternate‑day or intermittent schedules. This dosing strategy optimizes functional outcomes. 6
Dose escalation should follow the child’s growth, capping at a maximum body weight of 40 kg and a daily prednisone amount of 30–40 mg. This prevents overtreatment as the patient matures. 6

When children experience steroid‑induced behavioral side effects (e.g., hyperactivity, emotional lability), shifting the single dose to the afternoon—after school hours—may improve tolerance without compromising efficacy. 6

First‑line therapy for MIS‑C combines intravenous methylprednisolone at 1–2 mg/kg/day with intravenous immunoglobulin (IVIG) at 2 g/kg. This combination targets both inflammation and immune dysregulation. 7
For patients with refractory MIS‑C, methylprednisolone dosing can be intensified to 10–30 mg/kg/day IV. Higher doses are reserved for cases unresponsive to standard therapy. 7

For a 3‑year‑old child with an acute asthma flare, the recommended prednisolone dose is 1–2 mg/kg/day (maximum 60 mg/day) for 3–10 days; a 9 mg daily dose (≈0.6 mg/kg) provides only 32–64 % of the therapeutic range and is therefore inadequate for effective asthma control. 8

In very mild pediatric conditions that do not require standard anti‑inflammatory dosing, a low dose such as 0.3–0.5 mg/kg/day can be appropriate, reflecting a maintenance or tapering phase rather than acute therapy. 8

When a prednisolone course lasts fewer than 10 days, tapering is not required before stopping the medication, minimizing the risk of adrenal suppression. 8